Najeti Capital

PALAU PHARMA is a newly created biopharmaceutical company, whose mission is the discovery and development of drug candidates for the treatment of chronic inflammatory conditions. The company is a spin-out from GRUPO URIACH’s R&D Department, and so it benefits from the advantage of its integration in a well established Group which has been in the pharmaceutical business for over 160 years, and which is leading Spanish pharmaceutical company when it comes to R&D productivity.

Deep River Snacks offers kettle-cooked potato chips, baked fries, cheese popcorn, and multigrain tortilla chips that are healthy, delicious, and uniquely flavored. The company is highly regarded for its philanthropic efforts.

Annie's is natural and organic food. It is known for its premium, tasting products made with quality natural and organic ingredients like macaroni and cheese, snack crackers, fruit snacks, and graham crackers, and for its environmental social responsibility.

Triton Resources is the world leader in the design and manufacture of underwater logging equipment, management of large-scale reservoir harvest projects and marketing of certified eco-wood products.

Controlled Products Systems Group, Inc. operates as a wholesale distributor of perimeter access control equipment.

MVP is the designer, manufacturer and marketer of scented candles and home fragrance products sold directly to specialty and mass merchant retailers.

Crystax Pharmaceuticals is a leading structure-based drug discovery company. They identify and develop new lead compounds by a combination of structural and biophysical techniques that accelerate the process of drug discovery and bring higher quality molecules to the market. Core areas of expertise are: X-ray Crystallography, NMR, Fragment Screening and Hit Optimization by biophysical analysis and computational chemistry.

Floor & Decor Outlets is a growing retail chain, selling luxury hard surface stone, tile and wood products at discount prices, with the largest selection of in-stock products under one roof.

DataPath manufactures and distributes a range of IT-related products to its clients. DataPath's product portfolio consists of portable satellite terminals, deployable and fixed satellite terminals, and network mobility products. Furthermore, it offers cyber security consulting, managed security, and global field installation to its clients. DataPath was founded in 1996 and is based in Little Rock.

Prestolite Electric Incorporated is a global manufacturer and supplier of alternators, starters, other electrical equipment and services to the transportation, industrial and military industry. The Company was formed through the combination of a number of businesses whose manufacturing histories date back to the early 1900s, resulting in a long history of engineering excellence and innovative products. The Company's International presence provides customers with their application needs for products and service under the Prestolite Electric and Leece-Neville brand names. With manufacturing and distribution locations in the United States, Canada, Mexico, Europe, China and Hong Kong; Prestolite Electric will serve the needs for the original equipment and aftermarket applications. A wide global network of distribution associates facilitates product availability, service support and vehicle electrical education to keep vehicles and equipment in the value added mode for the user.

Oryzon Genomics is a biopharmaceutical company developing epigenetics-based therapeutics for patients with cancer and CNS disorders. Oryzon is able to identify and validate biomarkers and therapeutic targets through its epigenetic platform and turn them into advanced and personalized therapies. Oryzon Genomics has a growing portfolio, with two compounds in Phase II clinical trials: iadademstat (aka ORY-1001), a potent and selective LSD1 inhibitor for oncology, and vafidemstat (aka ORY-2001), a CNS optimized LSD1 inhibitor for the treatment of neurological diseases. The portfolio includes ORY-3001, a selective LSD1 inhibitor in preclinical development for the treatment of non-oncological diseases.